Position in TNGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,506,085
+$6,601,613 QoQ
Shares Held
496,036
+16.5% QoQ
Ownership
0.294%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#61
of 247 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Derivatives in TNGX
reported options exposure · as of Jun 30, 2025CallValue
$230,400
CallShares
45,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. TNGX ranks #65 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in TNGX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,506,085 | 496,036 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,904,472 | 425,644 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,254,015 | 593,004 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,881,368 | 1,295,401 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $230,400 | 45,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $9,074,196 | 1,772,304 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,015,176 | 1,470,932 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $771,406 | 249,646 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $127,936 | 14,911 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $151,574 | 19,090 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,916,124 | 294,558 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $1,027,779 | 309,572 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $782,743 | 198,163 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $211,808 | 29,215 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $743,935 | 205,507 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $595,930 | 131,552 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,679,999 | 485,488 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 BCTG | — | 38,414 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 BCTG | — | 80,190 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 BCTG | — | 230,950 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 BCTG | — | 231,250 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||